Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients

Science immunology - Tập 5 Số 52 - 2020
Baweleta Isho1, Kento T. Abe2,3, Michelle Zuo1, Alainna J Jamal4,5, Bhavisha Rathod3, Jenny H. Wang3, Zhijie Li2, Gary Chao1, Olga L. Rojas1, Yeo Myong Bang1, Annie Pu1, Natasha Christie-Holmes6, Christian Gervais7, Derek F. Ceccarelli3, Payman Samavarchi‐Tehrani3, Furkan Guvenc2, Patrick Budylowski6,8, Angel Li4, Aimee Paterson4, Feng Yun Yue1, Lina M. Marin9, Lauren Caldwell3, Jeffrey L. Wrana2,3, Karen Colwill3, Frank Sicheri2,3, Samira Mubareka10,11,12,13, Scott D. Gray‐Owen6,2, Steven J. Drews14, Walter L. Siqueira9, Miriam Barrios‐Rodiles3, Mario Ostrowski1,15,16,17, James M. Rini18,2, Yves Durocher7, Allison McGeer4,5,3, Jennifer L. Gommerman1, Anne‐Claude Gingras2,3
1Department of Immunology, University of Toronto, Toronto, ON, Canada
2Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
3Lunenfeld-Tanenbaum Research Institute at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
4Department of Microbiology, at Mount Sinai Hospital, Sinai Health System, Toronto, ON, Canada.
5Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada
6Combined Containment Level 3 Unit, University of Toronto,Toronto, ON, Canada
7Mammalian Cell Expression, Human Health Therapeutics Research Centre, National Research Council Canada, Montréal, QC, Canada.
8Institute of Medical Science, University of Toronto, Toronto, ON, Canada
9College of Dentistry, University of Saskatchewan, Saskatoon, SK, Canada
10Biological Sciences, Sunnybrook Research Institute
11Department of Laboratory Medicine and Molecular Diagnostics, Division of Microbiology, Sunnybrook Health Sciences Centre; Biological Sciences, Sunnybrook Research Institute; and Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada; Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada.
12Department of Laboratory Medicine and Pathology, University of Toronto, Toronto, ON, Canada
13Division of Infectious Diseases, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
14Canadian Blood Services, Edmonton, AB & Department of Laboratory Medicine and Pathology, University of Alberta, Edmonton, AB, Canada.
15Department of Medicine, University of Toronto, Toronto, ON, Canada
16Li Ka Shing Knowledge Institute
17St. Michael’s Hospital, Toronto, ON, Canada; Li Ka Shing Knowledge Institute.
18Department of Biochemistry, University of Toronto, Toronto, ON, Canada

Tóm tắt

Saliva is an alternative biofluid to serum for detecting and monitoring IgG to SARS-CoV-2 spike and RBD antigens in COVID-19.

Từ khóa


Tài liệu tham khảo

10.1038/s41564-020-0688-y

10.4161/mabs.2.1.10788

10.1038/s41591-020-0913-5

10.1038/s41591-020-0897-1

10.1126/sciimmunol.abc8413

10.1093/cid/ciaa344

10.3201/eid2607.200841

A. S. Iyera et al . Dynamics and significance of the antibody response to SARS-CoV-2 infection. MedRxiv https://www.medrxiv.org/content/10.1101/2020.07.18.20155374v1 (2020).

A. Wajnberg et al . SARS-CoV-2 infection induces robust neutralizing antibody responses that are 1 stable for at least three months. medRxiv https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1 (2020).

10.4049/jimmunol.2000839

T. J. Ripperger et al . Detection prevalence and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure. medRxiv https://www.medrxiv.org/content/10.1101/2020.08.14.20174490v1 (2020).

L. B. Rodda et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. medRxiv (2020). 10.1101/2020.08.11.20171843

K. H. D. Crawford et al . Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection. MedRxiv https://www.medrxiv.org/content/10.1101/2020.08.06.20169367v1 (2020).

10.1038/s41591-020-0965-6

10.1038/s41586-020-2196-x

J. Li et al. Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. bioRxiv 2020.2003.2031.019216 (2020).

10.1093/cid/ciaa149

10.1007/s00784-020-03248-x

10.3390/ijerph17072225

10.1084/jem.20062424

10.1007/s00430-008-0077-2

10.1177/0022034520918518

10.1016/S1473-3099(01)00169-4

K. T. Abe et al . A simple protein-based SARS-CoV-2 surrogate neutralization assay. bioRxiv https://www.biorxiv.org/content/10.1101/2020.07.10.197913v1 (2020).

10.1016/j.immuni.2020.03.020

10.3390/jcm9051491

10.1038/mi.2015.107

D. Sterlin et al . IgA dominates the early neutralizing antibody response to SARS-CoV-2. medRxiv https://www.medrxiv.org/content/10.1101/2020.06.10.20126532v1 (2020).

C. Cervia et al . Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19. bioRxiv https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1 (2020).

10.1017/S0950268800048019

10.1128/JCM.01368-15

10.1016/S0140-6736(87)92737-1

10.1016/j.cell.2018.11.035

S. E. Faustini et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv (2020).

P. R. Randad et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. medRxiv (2020).

10.1016/j.cell.2020.08.046

10.1016/j.immuni.2020.06.001

10.3389/fimmu.2013.00402

10.1111/j.1439-0450.1994.tb00252.x

Z. Wang et al . Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro. bioRxiv https://www.biorxiv.org/content/10.1101/2020.09.09.288555v1 (2020).

10.1038/s41467-020-18058-8

10.1084/jem.20161590

10.1126/science.1076071

10.1111/j.1537-2995.2006.00976.x

10.1126/science.abb2507

10.1016/j.jbiotec.2019.03.009

10.1016/j.jbiotec.2017.06.009

10.1534/g3.120.401554

S. Miersch et al . Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells. bioRxiv https://www.biorxiv.org/content/10.1101/2020.06.05.137349v2 (2020).

10.3201/eid2609.201495

10.1073/pnas.1707304114

10.1073/pnas.1218620110